Consequently, the goal of this research was to explore the antitumor impacts of ginsenoside Rh7 on gastric cancer cells by focusing on its regulation of SHCBP1 expression, β-catenin translocation, and EMT regulation to provide new insights into the GC targeted treatment. The gene discussed is SHCBP1; the disease is gastric cancer.